Carmat Total Artificial Heart as a Bridge to Transplant in Patients With Advanced Heart Failure
NCT: NCT04475393 · ACTIVE_NOT_RECRUITING
Publicidad
Resumen breve
The objective of this clinical investigation is to evaluate the efficacy and the safety of the Carmat Total Artificial Heart for the treatment of refractory advanced heart failure in transplant eligible patients.
Fuente oficial
Ver en ClinicalTrials.gov →Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.